Does thermal ablation plus chemotherapy improve survival in small-cell lung cancer ineligible for surgery?

Mao Sun, Yu Zhang, Yangyang Tang, Shubo Han, Wanyi Zhang, Ming Xie · 2026

Read Does thermal ablation plus chemotherapy improve survival in small-cell lung cancer ineligible for surgery? by Mao Sun, Yu Zhang, Yangyang Tang, Shubo Han, Wanyi Zhang, Ming Xie (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655891.txt.

Description

Mao Sun and co-authors ask if heat ablation plus chemotherapy extends life in small-cell lung cancer in a 2026 study. Surgery is not an option for many of these patients. Heat ablation is known to be safe in another lung cancer type. Evidence in small-cell disease, though, has been scarce.

Records came from a large United States cancer registry for 2000 to 2019. Over fifty-one thousand patients who got chemotherapy were tracked. Matching balanced the ablation-plus-drug group against drugs alone. The combined group lived longer overall and longer free of cancer death. Gains were clearest in patients aged seventy or above. Small tumors and early node stages also benefited most. No clear gain showed in larger or more spread cases. The authors call the combo a promising option for selected patients.

Catalog record

CREATORMao Sun, Yu Zhang, Yangyang Tang, Shubo Han, Wanyi Zhang, Ming Xie
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13655891

Browse the full library · About the Tower of Babel